Reuters, January 17, 2012

Treating stroke patients with clot-busting drugs costs U.S. hospitals substantially more than Medicare pays, a new study finds. The results are potentially concerning, researchers say, because in the long run, some hospitals may get out of the business of treating strokes.

Facebook icon
LinkedIn icon
Twitter icon